Evidence map›Paper›PMID 38296864›Full record

ArticleVisual computing for industry, biomedicine, and art2024

Convolutional neural network based data interpretable framework for Alzheimer's treatment planning.

Sazia Parvin, Sonia Farhana Nimmy, Md Sarwar Kamal

Abstract read
In one paragraph

Article in Visual computing for industry, biomedicine, and art, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sazia ParvinInformation Technology, Melbourne Polytechnic, Melbourne, VIC 3072, Australia. saziap@gmail.com.
Sonia Farhana NimmyFaculty of Economics and Business, University of New South Wales, Sydney, ACT 2612, Australia.
Md Sarwar KamalSchool of Computer Science, Faculty of Engineering and IT, University of Technology Sydney, Sydney, NSW 2007, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurological disorder that predominantly affects the brain. In the coming years, it is expected to spread rapidly, with limited progress in diagnostic techniques. Various machine learning (ML) and artificial intelligence (AI) algorithms have been employed to detect AD using single-modality data. However, recent developments in ML have enabled the application of these methods to multiple data sources and input modalities for AD prediction. In this study, we developed a framework that utilizes multimodal data (tabular data, magnetic resonance imaging (MRI) images, and genetic information) to classify AD. As part of the pre-processing phase, we generated a knowledge graph from the tabular data and MRI images. We employed graph neural networks for knowledge graph creation, and region-based convolutional neural network approach for image-to-knowledge graph generation. Additionally, we integrated various explainable AI (XAI) techniques to interpret and elucidate the prediction outcomes derived from multimodal data. Layer-wise relevance propagation was used to explain the layer-wise outcomes in the MRI images. We also incorporated submodular pick local interpretable model-agnostic explanations to interpret the decision-making process based on the tabular data provided. Genetic expression values play a crucial role in AD analysis. We used a graphical gene tree to identify genes associated with the disease. Moreover, a dashboard was designed to display XAI outcomes, enabling experts and medical professionals to easily comprehend the prediction results.

Indexed as

Alzheimer’s diseaseGraphical genes treeLayer-wise relevance propagationMultimodalRegion-based convolutional neural networkSubmodular pick local interpretable model-agnostic explanations

Identifiers

PMID38296864
PMCPMC10830981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.